Literature DB >> 32480432

A multicenter prospective validation study on disseminated intravascular coagulation in trauma-induced coagulopathy.

Satoshi Gando1,2, Atsushi Shiraishi3, Takeshi Wada2, Kazuma Yamakawa4, Seitaro Fujishima5, Daizoh Saitoh6, Shigeki Kushimoto7, Hiroshi Ogura8, Toshikazu Abe9,10, Yasuhiro Otomo11.   

Abstract

BACKGROUND: Trauma-induced coagulopathy (TIC) may progress to disseminated intravascular coagulation (DIC) due to dysregulated inflammatory and coagulofibrinolytic responses to trauma.
OBJECTIVES: We explored how DIC and TIC elicit the same coagulofibrinolytic changes which lead to massive transfusion.
METHODS: Severely injured trauma patients with an injury severity score ≥ 16 were prospectively included. Platelet counts, global markers of coagulation and fibrinolysis and specific markers of thrombin and plasmin generation, anticoagulation, endothelial injury, and inhibition of fibrinolysis were measured at presentation to the emergency department (0 hour) and 3 hour after arrival. The patients were subdivided into those with and without DIC and those with and without TIC using the 0-hour data. Time courses of specific markers and the frequency of massive transfusion were evaluated. The association of various variables with DIC development was also confirmed.
RESULTS: Two hundred and seventy-six patients were eligible for the analyses. The severity of injury (odds ratio; 1.038, P = .022) and thrombin generation (odds ratio; 1.014, P = .024) were associated with the development of DIC. Both DIC and TIC patients showed increased thrombin generation, insufficient anticoagulation controls, endothelial injury and increased fibrinolysis followed by elevated plasminogen activator inhibitor-1 levels at 0 and 3 hours. The frequency of massive transfusion was higher in both DIC (33.6% vs 7.9%, P < .001) and TIC (50.0% vs 13.3%, P < .001) patients than in those without DIC or TIC, respectively.
CONCLUSIONS: Disseminated intravascular coagulation and TIC evoked the same coagulofibrinolytic responses in severely injured trauma patients immediately after trauma and needed massive transfusion.
© 2020 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  coagulation; coagulopathy; disseminated intravascular coagulation; fibrinolysis; trauma

Mesh:

Year:  2020        PMID: 32480432     DOI: 10.1111/jth.14931

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  The α-globin chain of hemoglobin potentiates tissue plasminogen activator induced hyperfibrinolysis in vitro.

Authors:  Alexander P Morton; Jamie B Hadley; Arsen Ghasabyan; Marguerite R Kelher; Ernest E Moore; Shaun Bevers; Monika Dzieciatkowska; Kirk C Hansen; Mitchell S Cohen; Anirban Banerjee; Christopher C Silliman
Journal:  J Trauma Acute Care Surg       Date:  2022-01-01       Impact factor: 3.697

2.  Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength.

Authors:  Wilbert L Jones; Christopher R Ramos; Anirban Banerjee; Ernest E Moore; Kirk C Hansen; Julia R Coleman; Marguerite Kelher; Keith B Neeves; Christopher C Silliman; Jorge Di Paola; Brian Branchford
Journal:  Platelets       Date:  2022-06-05       Impact factor: 4.236

3.  Exploratory Investigation of the Plasma Proteome Associated with the Endotheliopathy of Trauma.

Authors:  Joseph D Krocker; Kyung Hyun Lee; Hanne H Henriksen; Yao-Wei Willa Wang; Erwin M Schoof; Sigurdur T Karvelsson; Óttar Rolfsson; Pär I Johansson; Claudia Pedroza; Charles E Wade
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

4.  Hyperoxemia during resuscitation of trauma patients and increased intensive care unit length of stay: inverse probability of treatment weighting analysis.

Authors:  Ryo Yamamoto; Seitaro Fujishima; Junichi Sasaki; Satoshi Gando; Daizoh Saitoh; Atsushi Shiraishi; Shigeki Kushimoto; Hiroshi Ogura; Toshikazu Abe; Toshihiko Mayumi; Joji Kotani; Taka-Aki Nakada; Yasukazu Shiino; Takehiko Tarui; Kohji Okamoto; Yuichiro Sakamoto; Shin-Ichiro Shiraishi; Kiyotsugu Takuma; Ryosuke Tsuruta; Tomohiko Masuno; Naoshi Takeyama; Norio Yamashita; Hiroto Ikeda; Masashi Ueyama; Toru Hifumi; Kazuma Yamakawa; Akiyoshi Hagiwara; Yasuhiro Otomo
Journal:  World J Emerg Surg       Date:  2021-04-29       Impact factor: 5.469

5.  Effects of tranexamic acid on coagulofibrinolytic markers during the early stage of severe trauma: A propensity score-matched analysis.

Authors:  Satoshi Gando; Atsushi Shiraishi; Takeshi Wada; Kazuma Yamakawa; Seitaro Fujishima; Daizoh Saitoh; Shigeki Kushimoto; Hiroshi Ogura; Toshikazu Abe; Toshihiko Mayumi; Junichi Sasaki; Joji Kotani; Naoshi Takeyama; Ryosuke Tsuruta; Kiyotsugu Takuma; Shin-Ichiro Shiraishi; Yasukazu Shiino; Taka-Aki Nakada; Kohji Okamoto; Yuichiro Sakamoto; Akiyoshi Hagiwara; Satoshi Fujimi; Yutaka Umemura; Yasuhiro Otomo
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

6.  Association of Histones With Coagulofibrinolytic Responses and Organ Dysfunction in Adult Post-cardiac Arrest Syndrome.

Authors:  Asumi Mizugaki; Takeshi Wada; Takumi Tsuchida; Satoshi Gando
Journal:  Front Cardiovasc Med       Date:  2022-06-28

7.  Impact of Pelvic Fracture Sites on Fibrinogen Depletion in Patients with Blunt Trauma: A Single-Center Cohort Study.

Authors:  Mayuko Kunii; Shunichiro Nakao; Yuko Nakagawa; Junya Shimazaki; Hiroshi Ogura
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

8.  Antithrombin activity levels for predicting long-term outcomes in the early phase of isolated traumatic brain injury.

Authors:  Masaki Takahashi; Takeshi Wada; Ryuta Nakae; Yu Fujiki; Takahiro Kanaya; Yasuhiro Takayama; Go Suzuki; Yasutaka Naoe; Shoji Yokobori
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.